Cargando…

Salivary lactoferrin as biomarker for Alzheimer's disease: Brain‐immunity interactions

OBJECTIVE: We aim to explain why salivary lactoferrin (Lf) levels are reduced in patients suffering mild cognitive impairment (MCI) and sporadic Alzheimer's disease (sAD).(1) We also will discuss if such Lf decrease could be due to a downregulation of the sAD associated systemic immunity. BACKG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bermejo‐Pareja, Félix, del Ser, Teodoro, Valentí, Meritxell, de la Fuente, Mónica, Bartolome, Fernando, Carro, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Theoretical Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984071/ https://www.ncbi.nlm.nih.gov/pubmed/32543760 http://dx.doi.org/10.1002/alz.12107

Ejemplares similares

Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin
por: Carro, Eva, et al.
Publicado: (2017)

Standardizing salivary lactoferrin measurements to obtain a robust diagnostic biomarker for Alzheimer's disease
por: Bartolome, Fernando, et al.
Publicado: (2021)

Salivary Lactoferrin Expression in a Mouse Model of Alzheimer’s Disease
por: Antequera, Desiree, et al.
Publicado: (2021)

Implication of salivary lactoferrin and periodontal-mediated infections in Alzheimer’s disease
por: Municio, Cristina, et al.
Publicado: (2023)

Decreased salivary lactoferrin levels are specific to Alzheimer's disease
por: González-Sánchez, Marta, et al.
Publicado: (2020)

Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients
por: Bartolomé, Fernando, et al.
Publicado: (2022)

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study
por: Bermejo-Pareja, Felix, et al.
Publicado: (2010)

Salivary lactoferrin is associated with cortical amyloid-beta load, cortical integrity, and memory in aging
por: Reseco, Lucia, et al.
Publicado: (2021)

Calmodulin levels in blood cells as a potential biomarker of Alzheimer’s disease
por: Esteras, Noemí, et al.
Publicado: (2013)

Identification of the protective mechanisms of Lactoferrin in the irradiated salivary gland
por: Sakai, Manabu, et al.
Publicado: (2017)

Lactoferrin and the development of salivary stones: a pilot study
por: Kraaij, Saskia, et al.
Publicado: (2022)

Relationship of Salivary Lactoferrin and Lysozyme Concentrations with Early Childhood Caries
por: Moslemi, Masoumeh, et al.
Publicado: (2015)

Amyloid-β impairs mitochondrial dynamics and autophagy in Alzheimer’s disease experimental models
por: de la Cueva, Macarena, et al.
Publicado: (2022)

Lactoferrin in Aseptic and Septic Inflammation
por: Lepanto, Maria Stefania, et al.
Publicado: (2019)

Author Correction: Amyloid-β impairs mitochondrial dynamics and autophagy in Alzheimer’s disease experimental models
por: de la Cueva, Macarena, et al.
Publicado: (2023)

Soluble Megalin is Reduced in Cerebrospinal Fluid Samples of Alzheimer’s Disease Patients
por: Spuch, Carlos, et al.
Publicado: (2015)

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
por: Ashton, Nicholas J., et al.
Publicado: (2019)

Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer’s Disease
por: Nara, Peter L., et al.
Publicado: (2021)

Impairment of Several Immune Functions and Redox State in Blood Cells of Alzheimer’s Disease Patients. Relevant Role of Neutrophils in Oxidative Stress
por: Vida, Carmen, et al.
Publicado: (2018)

To Boost or to Reset: The Role of Lactoferrin in Energy Metabolism
por: Ianiro, Giusi, et al.
Publicado: (2023)

Oxidative Stress in Tauopathies: From Cause to Therapy
por: Bartolome, Fernando, et al.
Publicado: (2022)

Lactoferrin in cerebrospinal fluid and saliva is not a diagnostic biomarker for Alzheimer's disease in a mixed memory clinic population
por: Gleerup, Helena Sophia, et al.
Publicado: (2021)

Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense
por: Valenti, Piera, et al.
Publicado: (2018)

Development and validation of a salivary tau biomarker in Alzheimer's disease
por: Pekeles, Heather, et al.
Publicado: (2018)

A review of the potential therapeutic role of statins in the treatment of Alzheimer’s disease: current research and opinion
por: Sánchez-Ferro, Álvaro, et al.
Publicado: (2013)

Lactoferrin: Lactoferrin: a modulator of immune and inflammatory responses
por: Legrand, D., et al.
Publicado: (2005)

Myopia Is Suppressed by Digested Lactoferrin or Holo-Lactoferrin Administration
por: Liang, Yifan, et al.
Publicado: (2023)

Antiviral Properties of Lactoferrin—A Natural Immunity Molecule
por: Berlutti, Francesca, et al.
Publicado: (2011)

Origin of MMP-8 and Lactoferrin levels from gingival crevicular fluid, salivary glands and whole saliva
por: Ramenzoni, Liza L., et al.
Publicado: (2021)

Lactoferrin: A Natural Glycoprotein Involved in Iron and Inflammatory Homeostasis
por: Rosa, Luigi, et al.
Publicado: (2017)

Increased YKL-40 but Not C-Reactive Protein Levels in Patients with Alzheimer’s Disease
por: Blanco-Palmero, Víctor Antonio, et al.
Publicado: (2021)

Neurología clínica básica
por: Bermejo Pareja, Félix
Publicado: (1991)

Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD
por: Buderus, Stephan, et al.
Publicado: (2015)

Aquaporin 5 in Alzheimer’s disease: a link between oral and brain pathology?
por: Municio, Cristina, et al.
Publicado: (2022)

Non-steroidal anti-inflammatory drugs use in older adults decreases risk of Alzheimer’s disease mortality
por: Benito-León, Julián, et al.
Publicado: (2019)

The Role of Salivary Biomarkers in the Early Diagnosis of Alzheimer’s Disease and Parkinson’s Disease
por: Pawlik, Patrycja, et al.
Publicado: (2021)

Hypothesis: apo‐lactoferrin–Galantamine Proteo‐alkaloid Conjugate for Alzheimer's disease Intervention
por: Akilo, Olufemi D., et al.
Publicado: (2018)

Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease
por: Arnsten, Amy F. T., et al.
Publicado: (2020)

From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein‐Templated Synthesis
por: Nozal, Vanesa, et al.
Publicado: (2021)

Reciprocal Interactions between Lactoferrin and Bacterial Endotoxins and Their Role in the Regulation of the Immune Response
por: Latorre, Daniela, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_7fvfl71bqvcljf0j639p0jju0d